#United States #San Diego #Robbins LLP #Nano-X #NNOX Class Action

Call to Action for NNOX Investors

Robbins LLP, a renowned firm specializing in shareholder rights litigation, has called upon stockholders of Nano-X Imaging Ltd., trading under the NASDAQ ticker NNOX, who have experienced financial losses, to consider participating in a newly initiated class action lawsuit. This action concerns investors who purchased or otherwise acquired NNOX securities between March 31, 2025, and April 17, 2026, during which significant allegations of misinformation were raised against the company's operational and financial disclosures.

Background on Nano-X Imaging Ltd.

Nano-X Imaging is known for developing a commercial-grade tomographic imaging device paired with a digital X-ray source, aspiring to innovate within the medical imaging sector. However, recent developments have cast doubt on the company’s transparency and authenticity regarding its operational efficiency and financial health, leading to a noticeable decline in stock value.

The allegations suggest that the company overstated its operational efficiency and projected demand for its products. Reports indicate that Nano-X’s production capabilities were found misaligned with actual market demand, contributing to increased operational costs and an unsustainable cash burn rate. Consequently, these discrepancies heightened concerns that the company may need to implement drastic remedial measures, potentially leading to restructuring costs and impairment charges that would significantly affect shareholders.

Recent Developments

On April 20, 2026, Nano-X reported a staggering net loss of $33.4 million for the fourth quarter, which included a $17.5 million charge attributed to asset impairments directly linked to restructuring initiatives. Following this disclosure, the share price saw a steep decline of 24.39%, closing at $2.155 per share. This immediate drop in stock value has triggered significant concern among investors regarding the integrity of the company's prior announcements and overall stability.

What Investors Need to Know

The class action seeks to hold Nano-X accountable for allegedly misleading statements that failed to provide an accurate picture of its operations and financial positioning. Investors interested in being lead plaintiffs must submit their documentation to the court by August 11, 2026. The role of the lead plaintiff is crucial, as this individual will represent the collective interests of all class members during the litigation process.

For investors who prefer not to engage directly but wish to remain involved, they can choose to be absent class members, thus still potentially benefiting from any settlements that may arise without formally participating.

Robbins LLP operates on a contingency fee basis, meaning that shareholders will not incur any costs unless the case is successful. This structure ensures that the firm is motivated to secure a beneficial outcome for its clients, reinforcing its commitment to shareholder rights and corporate accountability.

About Robbins LLP

Since its establishment in 2002, Robbins LLP has earned recognition as a leader in advocating for shareholders' rights, guiding them in recovering losses and enhancing corporate governance practices. With a mission to hold executives accountable for their actions, the firm remains vigilant in monitoring corporate misconduct. Interested individuals can stay informed about the class action's progress by signing up for updates via the firm’s Stock Watch program.

For more information or to discuss potential participation in this class action, stockholders can fill out a contact form or reach out directly to attorney Aaron Dumas, Jr., via phone at (800) 350-6003. The time to act is now, as accountability in the financial world becomes increasingly critical for ensuring investor confidence and corporate integrity.